Interventional Glaucoma

Latest News

Nicox and Kowa sign agreement for exclusive rights to glaucoma treatment NCX 470
Nicox and Kowa sign agreement for exclusive rights to glaucoma treatment NCX 470

July 20th 2025

Under the terms of the agreement, Kowa receives exclusive rights to develop and commercialize NCX 470 in the US and all other territories of the world excluding Japan, China, Korea, and Southeast Asia.

MidWest Eye Center among first in Midwest to adopt new noncontact laser for glaucoma
MidWest Eye Center among first in Midwest to adopt new noncontact laser for glaucoma

July 15th 2025

PER-001 shows vision restoration in glaucoma and DR in phase 2a trials
PER-001 shows vision restoration in glaucoma and DR in phase 2a trials

July 7th 2025

Nicox completes phase 3 Denali trial of NCX 470 in open-angle glaucoma or ocular hypertension
Nicox completes phase 3 Denali trial of NCX 470 in open-angle glaucoma or ocular hypertension

June 30th 2025

Q&A: Sevgi Gurkan, MD, on the PER-001 for glaucoma and DR
Q&A: Sevgi Gurkan, MD, on the PER-001 for glaucoma and DR

June 28th 2025

Latest CME Events & Activities

Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (CME Track)

View More

Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (COPE Track)

View More

Burst CME Plus™ - Unveiling Pharmacological Advances in nAMD & DME: From Durability to Applicability

View More

Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (CME Credit)

View More

Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (COPE Credit)

View More

Retina Specialists: Join us in Long Beach

July 31, 2025 - August 2, 2025

Register Now!

SimulatED™: Pioneering Treat-and-Extend Therapy—The Impact of Early Application

View More

Rapid Reviews in Retina™: Emerging Updates from Summer 2024 - Addressing the Wealth of New Data in Treatments for nAMD and DME

View More

3rd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between

September 6, 2025

Register Now!

Cases & Conversations™: Real World Review of Treat and Extend Strategies for Neovascular Retinal Disease

View More

Clinical Consultations™: Novel Therapeutic Targets in Neovascular Retinal Diseases – A Focus on the Roles of VEGF-C/D

View More

EyeCon 2025

September 26-27, 2025

Register Now!

Optometrists: Earn COPE CE Credits in Portland or Virtually

October 16-17, 2025

Register Now!

Join us at The Ophthalmology Meeting in Orlando this October

October 18, 2025

Register Now!

Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (Cope Credit)

View More

Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (CME Track)

View More

Community Practice Connections™: Transforming Treatment in nAMD, DME, and DR – Keeping an Eye on Optimal Outcomes

View More

(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

View More

(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

View More

Expert Perspectives on Technological Advances in Cataract Surgery

View More

Expanding Treatment Options for Demodex Blepharitis: Patient-Centric Approaches to Therapy

View More

Burst CME™ Part 3: Initiating Early Intervention in Patients With Glaucoma Who Fail Pharmacological Therapy

View More

(CME Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes

View More

(CME Track) Burst CME™ Part 1: Insights Into Glaucoma and the Need for Early Intervention

View More

Interventional Glaucoma Treatment: Evolving Paradigms for Addressing Unmet Needs

View More

(COPE Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes

View More

(CME Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention

View More

(COPE Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention

View More

(COPE Track) Leveraging Rho Kinase Inhibition in Glaucoma Management — How Can Novel Treatment Pathways Impact Patient Outcomes?

View More

(CME Track) Leveraging Rho Kinase Inhibition in Glaucoma Management — How Can Novel Treatment Pathways Impact Patient Outcomes?

View More

© 2025 MJH Life Sciences

All rights reserved.